Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

PNMA1 Polyclonal Antibody, FITC Conjugated

Product Specifications

Background

Paraneoplastic neurological disorders (PNDs) are rare syndromes that are caused by, or associated with, an underlying neoplasm. The most common neoplasm among young male patients is testicular cancer, but the leading cause among other patients is lung cancer. Most PNDs are caused by an immune response against onconeural antigens, causing progressive neurological damage. The paraneoplastic antigen MA family contains three known members: MA1, MA2 and MA3. MA1, also designated neuron- and testis-specific protein 1, is a nucleolar protein in normal cells but localizes to the cytoplasm of tumor cells. MA2, also designated onconeuronal antigen MA2, is a nucleolar protein expressed in brain and testis. MA3 is highly expressed in brain and testis and is expressed at low levels in heart, trachea and kidney.

Synonyms

37 kDa neuronal protein; MA1; Paraneoplastic antigen MA1

Cellular Locus

Nucleus

Host

Rabbit

Immunogen

165-270/353

Target

PNMA1

Clonality

Polyclonal

Isotype

IgG

Conjugation

FITC

Source

KLH conjugated synthetic peptide derived from human PNMA1

Applications

IF (IHC-P), IF (IHC-F), IF (ICC)

Purification

Purified by Protein A.

Excitation Emission

494nm/518nm

Concentration

1µg/µl

Dilution

IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)

Buffer

Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Modification

Unmodified

Storage Conditions

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Predicted Cross Reactivity

Human, Mouse, Rat, Dog, Cow, Sheep, Pig, Horse, Rabbit

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Recombinant Vibrio vulnificus UPF0229 protein VV1_2091 (VV1_2091)
MBS1189882-01 0.02 mg (E-Coli)

Recombinant Vibrio vulnificus UPF0229 protein VV1_2091 (VV1_2091)

Ask
View Details
Recombinant Vibrio vulnificus UPF0229 protein VV1_2091 (VV1_2091)
MBS1189882-02 0.02 mg (Yeast)

Recombinant Vibrio vulnificus UPF0229 protein VV1_2091 (VV1_2091)

Ask
View Details
Recombinant Vibrio vulnificus UPF0229 protein VV1_2091 (VV1_2091)
MBS1189882-03 0.1 mg (E-Coli)

Recombinant Vibrio vulnificus UPF0229 protein VV1_2091 (VV1_2091)

Ask
View Details
Recombinant Vibrio vulnificus UPF0229 protein VV1_2091 (VV1_2091)
MBS1189882-04 0.1 mg (Yeast)

Recombinant Vibrio vulnificus UPF0229 protein VV1_2091 (VV1_2091)

Ask
View Details
Recombinant Vibrio vulnificus UPF0229 protein VV1_2091 (VV1_2091)
MBS1189882-05 0.02 mg (Baculovirus)

Recombinant Vibrio vulnificus UPF0229 protein VV1_2091 (VV1_2091)

Ask
View Details
Recombinant Vibrio vulnificus UPF0229 protein VV1_2091 (VV1_2091)
MBS1189882-06 0.02 mg (Mammalian-Cell)

Recombinant Vibrio vulnificus UPF0229 protein VV1_2091 (VV1_2091)

Ask
View Details